You are here

Article info

Article menu

Download PDFPDF

Research Article
Enhancing adoptive cancer immunotherapy with Vγ2Vδ2 T cells through pulse zoledronate stimulation

Authors

  • Mohanad H. Nada Division of Immunology, Department of Internal MedicineUniversity of Iowa Carver College of Medicine 52242 Iowa City IA USA Department of Veterans Affairs, Iowa City Health Care System 52246 Iowa City IA USA Interdisciplinary Graduate Program in ImmunologyUniversity of Iowa Carver College of Medicine 52242 Iowa City IA USA Department of Pathology, College of MedicineTikrit University Tikrit Iraq PubMed articlesGoogle scholar articles
  • Hong Wang Division of Immunology, Department of Internal MedicineUniversity of Iowa Carver College of Medicine 52242 Iowa City IA USA Department of Veterans Affairs, Iowa City Health Care System 52246 Iowa City IA USA PubMed articlesGoogle scholar articles
  • Grefachew Workalemahu Division of Immunology, Department of Internal MedicineUniversity of Iowa Carver College of Medicine 52242 Iowa City IA USA Department of Veterans Affairs, Iowa City Health Care System 52246 Iowa City IA USA PubMed articlesGoogle scholar articles
  • Yoshimasa Tanaka Center for Bioinformatics and Molecular Medicine, Graduate School of Biomedical SciencesNagasaki University 1-12-4 Sakamoto 852-8523 Nagasaki Japan PubMed articlesGoogle scholar articles
  • Craig T. Morita Division of Immunology, Department of Internal MedicineUniversity of Iowa Carver College of Medicine 52242 Iowa City IA USA Department of Veterans Affairs, Iowa City Health Care System 52246 Iowa City IA USA Interdisciplinary Graduate Program in ImmunologyUniversity of Iowa Carver College of Medicine 52242 Iowa City IA USA PubMed articlesGoogle scholar articles
  1. ↵a mohanadhameednada-nada{at}uiowa.edu
  2. ↵b hong-wang-1{at}uiowa.edu
  3. ↵c grefachew-workalemahu{at}uiowa.edu
  4. ↵d ystanaka{at}nagasaki-u.ac.jp
  5. ↵e craig-morita{at}uiowa.edu
View Full Text

Citation

Nada MH, Wang H, Workalemahu G, et al
Enhancing adoptive cancer immunotherapy with Vγ2Vδ2 T cells through pulse zoledronate stimulation
Journal for ImmunoTherapy of Cancer 2017;5:9. doi: 10.1186/s40425-017-0209-6

Publication history

  • Received June 11, 2016
  • Accepted January 6, 2017
  • First published February 21, 2017.
Online issue publication 
February 09, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© The Author(s). Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.